We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Homology Medicines, Inc. (FIXX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Published: September 2018
Pages: 32
Code: 48F6C620A19CD0EE6B20BA17239F8258
Format: PDF
Publisher GlobalData
From Add to basket
$ 250.00

Additonal Information

  • Homology Medicines, Inc. (Homology Medicines) is a pre-clinical stage biopharmaceutical company engaged in translating gene editing and gene therapy into novel treatment for patients suffering from rare genetic diseases. It offers HMI-102 product, which is in clinical stage for the treatment of Phenylketonuria (PKU). The company’s gene editing technology is used in DNA repairs, and gene therapy approach along with AAVHSC vectors delivers a functional gene to treat monogenic diseases in the liver, lung, none marrow and eye. Genetic medicines are used for treating newborn and pediatric patients. Homology Medicines is headquartered in Bedford, Massachusetts, the US.
  • provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
  • GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Reasons to buy

Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company.
Add to basket
  • Table of Contents
  • Table of Contents 3
  • List of Tables 4
  • List of Figures 4
  • Homology Medicines, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
  • Homology Medicines, Inc., Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
  • Homology Medicines, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
  • Homology Medicines, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
  • Homology Medicines, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
  • Homology Medicines, Inc., Pharmaceuticals & Healthcare, Deal Details 10
  • Venture Financing 10
  • Homology Medicines Raises USD83.5 Million in Series B Financing 10
  • Homology Medicines Raises USD43.5 Million in Series A Financing Round 12
  • Homology Medicines Raises USD23 Million in Venture Financing 14
  • Partnerships 15
  • Homology Medicines Enters into Agreement with Novartis 15
  • Licensing Agreements 16
  • Homology Medicines Amends its Licensing Agreement with California Institute of Technology 16
  • City of Hope Signs Licensing Agreement with Homology Medicines 17
  • Equity Offering 18
  • Homology Medicines Raises USD165.6 Million in IPO 18
  • Homology Medicines, Inc. - Key Competitors 20
  • Homology Medicines, Inc. - Key Employees 21
  • Homology Medicines, Inc. - Locations And Subsidiaries 22
  • Head Office 22
  • Recent Developments 23
  • Financial Announcements 23
  • Aug 13, 2018: Homology Medicines reports second quarter 2018 financial results 23
  • May 14, 2018: Homology Medicines Announces First Quarter 2018 Financial Results 25
  • Corporate Communications 27
  • Mar 15, 2018: Homology Medicines Appoints Mary Thistle to Board of Directors 27
  • Jan 17, 2018: Homology Medicines Appoints Matthew R. Patterson to Board of Directors 28
  • Apr 04, 2017: Homology Medicines Appoints Brad Smith as Chief Financial Officer 29
  • Product News 30
  • Jul 16, 2018: Homology Medicines announces peer-reviewed publication demonstrating efficient and precise in vivo gene editing capabilities of nuclease-free technology platform 30
  • Mar 01, 2018: Homology Medicines Announces Peer-Reviewed Publication Indicating Low Prevalence of Pre-existing Neutralizing Antibodies to its Human-Derived AAVHSC Vectors 31
  • Appendix 32
  • Methodology 32
  • About GlobalData 32
  • Contact Us 32
  • Disclaimer 32
  • List of Tables
  • Homology Medicines, Inc., Pharmaceuticals & Healthcare, Key Facts, 2017 2
  • Homology Medicines, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
  • Homology Medicines, Inc., Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
  • Homology Medicines, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
  • Homology Medicines, Inc., Deals By Therapy Area, 2012 to YTD 2018 8
  • Homology Medicines, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
  • Homology Medicines Raises USD83.5 Million in Series B Financing 10
  • Homology Medicines Raises USD43.5 Million in Series A Financing Round 12
  • Homology Medicines Raises USD23 Million in Venture Financing 14
  • Homology Medicines Enters into Agreement with Novartis 15
  • Homology Medicines Amends its Licensing Agreement with California Institute of Technology 16
  • City of Hope Signs Licensing Agreement with Homology Medicines 17
  • Homology Medicines Raises USD165.6 Million in IPO 18
  • Homology Medicines, Inc., Key Competitors 20
  • Homology Medicines, Inc., Key Employees 21
  • List of Figures
  • Homology Medicines, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
  • Homology Medicines, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
  • Homology Medicines, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
  • Homology Medicines, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
  • Homology Medicines, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
  • Homology Medicines, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
  • Homology Medicines, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
  • Homology Medicines, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Keywords
;